Welcome to Cochlear ProNews, your professional resource for clinical updates, surgical insights and audiological advancements in implantable hearing solutions. Stay current with peer-reviewed articles, continuing education opportunities and the latest on Cochlear hearing implant technologies. Subscribe today to join our community of experts and stay connected to the latest in hearing healthcare.

Featured posts

Cochlear Implants
by Parri Tantillo

ReSound Announces New Dedicated Bimodal Hearing Aids for Cochlear® Nucleus® Sound Processors

Through the Smart Hearing Alliance, Cochlear and ReSound are dedicated to supporting your patients throughout their hearing journey. Building on this shared commitment, ReSound is introducing ReSound Sensia™ Bimodal and ReSound Enzo™ IA Bimodal, designed to work with Cochlear® Nucleus® Sound Processors. These purpose-built solutions work together, supporting integrated performance, reliable connectivity and a more connected hearing experience. This announcement reflects continued […]

Read More
Bone Conduction
by Christy LaPlante

Cochlear Introduces the New Osia® 3 Sound Processor

[LONE TREE, CO] – July 13, 2026: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announces FDA clearance of the new Cochlear® Osia® 3 Sound Processor, the newest advancement of the award-winning Osia System.‡ Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided […]

Read More
Cochlear Implants
by Weston Adkins

Introducing the Cochlear™ Care Consensus: Q&A with René Gifford, PhD

What you’ll learn: Estimated reading time is 15 minutes. In this Q&A, Dr. René Gifford, Chief of Research and Audiology at Hearts for Hearing, offers an early look at the newly developed Cochlear Care Consensus. She discusses why this collaborative effort matters, what it means for clinical decision-making, and how it can help patients achieve their full hearing potential. Q: How have […]

Read More

All posts

→
Cochlear logo - white

©Cochlear Limited 2026. All rights reserved. For a full list of Cochlear’s trademarks, please visit our Terms of Use page. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

 

This blog is intended to serve as a resource for clinicians to help keep up to date with current clinical literature and is intended for professionals only. Clinical literature is based on research, which may include the experimental use of new or currently available products and technologies. Therefore, literature presented on this blog may represent use of Cochlear products that does not align with the intended use or indications approved by regulatory bodies, also known as off-label use. Cochlear does not condone any off-label use of its products, and it is not Cochlear’s intent to promote off-label use by providing this blog as a resource for healthcare professionals.

 

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

 

Cochlear ProNews is monitored Monday through Friday, excluding some holidays. Questions and inquiries submitted over the weekends or holidays may see a delay in response. For immediate assistance please contact us directly. You are solely responsible for your interactions with other members of our Websites. Cochlear reserves the right, but has no obligation, to monitor disputes or communications between you and other members of our Websites. For a full list of Cochlear’s terms of use, click here.